{"id":"https://openalex.org/W2233102467","doi":"https://doi.org/10.1111/vox.12375","title":"Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing","display_name":"Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing","publication_year":2016,"publication_date":"2016-01-14","ids":{"openalex":"https://openalex.org/W2233102467","doi":"https://doi.org/10.1111/vox.12375","mag":"2233102467","pmid":"https://pubmed.ncbi.nlm.nih.gov/26765975"},"language":"en","primary_location":{"id":"doi:10.1111/vox.12375","doi":"https://doi.org/10.1111/vox.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/vox.12375","pdf_url":null,"source":{"id":"https://openalex.org/S56953219","display_name":"Vox Sanguinis","issn_l":"0042-9007","issn":["0042-9007","1423-0410"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sanguinis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003451116","display_name":"Hung\u2010Chih Yang","orcid":"https://orcid.org/0000-0003-3864-9895","observed_orcids":["https://orcid.org/0000-0003-3864-9895"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Yang","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008758398","display_name":"Steven A. Anderson","orcid":"https://orcid.org/0000-0002-2517-0271","observed_orcids":["https://orcid.org/0000-0002-2517-0271"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. A. Anderson","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087332112","display_name":"Richard A. Forshee","orcid":"https://orcid.org/0000-0002-5805-2837","observed_orcids":["https://orcid.org/0000-0002-5805-2837"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Forshee","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065158218","display_name":"ALAN E. WILLIAMS","orcid":"https://orcid.org/0000-0002-2396-457X","observed_orcids":["https://orcid.org/0000-0002-2396-457X"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Williams","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060113453","display_name":"Jay S. Epstein","orcid":"https://orcid.org/0000-0003-2293-9062","observed_orcids":["https://orcid.org/0000-0003-2293-9062"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. S. Epstein","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000410098","display_name":"Peter W Marks","orcid":"https://orcid.org/0000-0001-5619-4404","observed_orcids":["https://orcid.org/0000-0001-5619-4404"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P. W. Marks","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000410098"],"corresponding_institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":4.5357,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.9350381,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"110","issue":"4","first_page":"324","last_page":"328"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nucleic-acid-testing","display_name":"nucleic acid testing","score":0.9459999799728394},{"id":"https://openalex.org/keywords/blood-donor-screening","display_name":"blood donor screening","score":0.8360000252723694},{"id":"https://openalex.org/keywords/personalized-risk-assessment","display_name":"individual risk assessment","score":0.8970000147819519},{"id":"https://openalex.org/keywords/donor-deferral","display_name":"donor deferral","score":0.6389999985694885},{"id":"https://openalex.org/keywords/transfusion-transmitted-infections","display_name":"transfusion-transmitted infections","score":0.8199999928474426},{"id":"https://openalex.org/keywords/transfusion-safety","display_name":"transfusion safety","score":0.7590000033378601},{"id":"https://openalex.org/keywords/risk-based-screening","display_name":"risk-based screening","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C182516595","wikidata":"https://www.wikidata.org/wiki/Q376660","display_name":"Nat","level":2,"score":0.697701632976532},{"id":"https://openalex.org/C152163801","wikidata":"https://www.wikidata.org/wiki/Q2146057","display_name":"Residual risk","level":2,"score":0.631779134273529},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.6108194589614868},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5986994504928589},{"id":"https://openalex.org/C2780014101","wikidata":"https://www.wikidata.org/wiki/Q183605","display_name":"Blood transfusion","level":2,"score":0.5822862386703491},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5815906524658203},{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.49368390440940857},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.4921082854270935},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.46711716055870056},{"id":"https://openalex.org/C2993617979","wikidata":"https://www.wikidata.org/wiki/Q53467","display_name":"Blood donor","level":2,"score":0.46333491802215576},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3869442045688629},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.35184070467948914},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3282524347305298},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32029062509536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.258760541677475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2550400495529175},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.18387967348098755},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.12437203526496887},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10928556323051453},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001782","descriptor_name":"Blood Donors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001803","descriptor_name":"Blood Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000635","qualifier_name":"transmission","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021141","descriptor_name":"Nucleic Acid Amplification Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058731","descriptor_name":"Blood Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/vox.12375","doi":"https://doi.org/10.1111/vox.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/vox.12375","pdf_url":null,"source":{"id":"https://openalex.org/S56953219","display_name":"Vox Sanguinis","issn_l":"0042-9007","issn":["0042-9007","1423-0410"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sanguinis","raw_type":"journal-article"},{"id":"pmid:26765975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26765975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox sanguinis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1496791474","https://openalex.org/W1572150628","https://openalex.org/W1641280389","https://openalex.org/W1771935400","https://openalex.org/W1970404712","https://openalex.org/W2003135661","https://openalex.org/W2041629871","https://openalex.org/W2118783000","https://openalex.org/W2143575560","https://openalex.org/W2146151494","https://openalex.org/W4242449005"],"related_works":["https://openalex.org/W4240714331","https://openalex.org/W2114098199","https://openalex.org/W2172034498","https://openalex.org/W2028491380","https://openalex.org/W2892927211","https://openalex.org/W2915594681","https://openalex.org/W1588980062","https://openalex.org/W2068318107","https://openalex.org/W4318046516","https://openalex.org/W1974793859"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,66],"OBJECTIVES:":[2],"The":[3,33],"safety":[4],"of":[5,12,27,37,51,61,73,89,101,141,174,185,191,203,210,234],"the":[6,49,70,86,99,110,139,149,154,183,189,200,232,240],"blood":[7,44,193,219],"supply":[8],"in":[9,43,59,109,113,153,231,239],"a":[10,125],"number":[11,72,100],"countries":[13],"is":[14,221],"achieved":[15],"by":[16,168],"interventions":[17],"that":[18,105,152],"include":[19],"behaviour-based":[20],"time-limited":[21],"or":[22,146],"indefinite":[23],"deferrals":[24,55],"and":[25,84,128,213],"screening":[26,46,94,126,145,220],"donated":[28],"units":[29,104,164],"for":[30,134,218],"transfusion-transmitted":[31],"infections.":[32],"relatively":[34],"high":[35],"sensitivity":[36],"nucleic":[38,169],"acid":[39,170],"testing":[40],"(NAT)":[41],"used":[42,96],"donor":[45,93,147,211],"has":[47],"raised":[48],"question":[50],"whether":[52],"such":[53],"time-based":[54],"can":[56],"be":[57,224],"eliminated":[58],"favour":[60],"individual":[62,115,143,206],"risk":[63,116,184,207,233],"assessment.":[64],"MATERIALS":[65],"METHODS:":[67],"Data":[68],"on":[69,85,216],"annual":[71],"incident":[74],"human":[75],"immunodeficiency":[76],"virus":[77],"(HIV)":[78],"infections":[79],"associated":[80,225],"with":[81,226],"various":[82],"behaviours":[83],"performance":[87],"characteristics":[88],"NAT":[90,217],"applied":[91],"to":[92,97,182,223],"were":[95],"model":[98,150],"potentially":[102,172],"infected":[103],"might":[106],"escape":[107,166],"detection":[108,167],"worst-case":[111,201],"scenario":[112,202],"which":[114],"assessment":[117],"was":[118,121],"implemented,":[119],"but":[120],"not":[122,131],"effective":[123,142],"as":[124],"tool,":[127],"donors":[129],"did":[130],"otherwise":[132],"self-select":[133],"lower":[135],"risk.":[136],"RESULTS:":[137],"In":[138],"absence":[140,209],"risk-based":[144],"self-selection,":[148],"predicts":[151],"United":[155,241],"States,":[156],"an":[157,227],"additional":[158],"39":[159],"(95%":[160,178],"CI":[161,179],"35-43)":[162],"HIV-infected":[163],"would":[165],"testing,":[171],"capable":[173],"exposing":[175],"approximately":[176,228],"68":[177],"61-75)":[180],"individuals":[181],"HIV":[186,235],"infection":[187],"through":[188,237],"administration":[190],"prepared":[192],"components.":[194],"CONCLUSION:":[195],"Despite":[196],"some":[197],"inherent":[198],"uncertainty,":[199],"completely":[204],"ineffective":[205],"assessment,":[208],"self-selection":[212],"increased":[214],"reliance":[215],"estimated":[222],"fourfold":[229],"increase":[230],"exposure":[236],"transfusion":[238],"States.":[242]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}